Zienab Shahada, Maysoun Kudsi, Lama Youssef, Younes Kabalan
{"title":"The relationship of vitamin D to the MHAQ index, activity disease, and inflammation in a sample of Syrian rheumatoid disease patients","authors":"Zienab Shahada, Maysoun Kudsi, Lama Youssef, Younes Kabalan","doi":"10.1097/gh9.0000000000000441","DOIUrl":null,"url":null,"abstract":"\n \n Vitamin D has an immunomodulatory and anti-inflammatory role, and its deficiency has been linked with many autoimmune disorders, including rheumatoid arthritis (RA). The correlation ship between the severity of RA and serum levels of vitamin D is a subject of immense interest and therapeutic implications.\n \n \n \n A total of 100 patients previously diagnosed with RA were collected from visitors to the rheumatology clinic at the university hospital and their ages were over 18 years. The serum vitamin D value and the C-reactive protein (CRP) value were measured, and the Disease Activity Score CRP28 (DAS28CRP) and Modified Health Assessment Questionnaire (MHAQ) score were calculated to determine the severity and effectiveness of the disease and its relationship to vitamin D deficiency.\n \n \n \n The average age of the patients ranged according to the patient’s age (46.03±11.291), we note that individuals whose ages ranged from 26 to 65 accounted for the largest percentage (94%), 83% of women (83) and 17% men (17), and the mean score for sun exposure was 15.80±5.446. Patients were individuals diagnosed with the disease between 5 and 10 years were the highest group, with a percentage of 31%. A total of 72% of the patients were not treated with corticosteroids, and 43% of the patients were treated with vitamin D. We found that the number of patients using biologic medications was 18%, and the number of patients using disease-modifying anti-rheumatic drugs was 88%. The mean of DAS28 was moderate in 63% of patients, and the average of the MHAQ score was 0.80±0.334. We found that there is no statically significant correlation between the serum vitamin D level and DAS28/CRP (P=0.733), and there is also no statically significant correlation between the serum value of vitamin D and the medications used, whether biological or disease-modifying anti-rheumatic drugs (P=0.361). In addition, there is also no significant correlation between the serum vitamin D level and MHAQ score (P=0.100).\n \n \n \n There was no significant relationship between vitamin D deficiency and the disease activity or severity in a sample of patients with RA.\n","PeriodicalId":506642,"journal":{"name":"International Journal of Surgery: Global Health","volume":" 22","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Surgery: Global Health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/gh9.0000000000000441","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Vitamin D has an immunomodulatory and anti-inflammatory role, and its deficiency has been linked with many autoimmune disorders, including rheumatoid arthritis (RA). The correlation ship between the severity of RA and serum levels of vitamin D is a subject of immense interest and therapeutic implications.
A total of 100 patients previously diagnosed with RA were collected from visitors to the rheumatology clinic at the university hospital and their ages were over 18 years. The serum vitamin D value and the C-reactive protein (CRP) value were measured, and the Disease Activity Score CRP28 (DAS28CRP) and Modified Health Assessment Questionnaire (MHAQ) score were calculated to determine the severity and effectiveness of the disease and its relationship to vitamin D deficiency.
The average age of the patients ranged according to the patient’s age (46.03±11.291), we note that individuals whose ages ranged from 26 to 65 accounted for the largest percentage (94%), 83% of women (83) and 17% men (17), and the mean score for sun exposure was 15.80±5.446. Patients were individuals diagnosed with the disease between 5 and 10 years were the highest group, with a percentage of 31%. A total of 72% of the patients were not treated with corticosteroids, and 43% of the patients were treated with vitamin D. We found that the number of patients using biologic medications was 18%, and the number of patients using disease-modifying anti-rheumatic drugs was 88%. The mean of DAS28 was moderate in 63% of patients, and the average of the MHAQ score was 0.80±0.334. We found that there is no statically significant correlation between the serum vitamin D level and DAS28/CRP (P=0.733), and there is also no statically significant correlation between the serum value of vitamin D and the medications used, whether biological or disease-modifying anti-rheumatic drugs (P=0.361). In addition, there is also no significant correlation between the serum vitamin D level and MHAQ score (P=0.100).
There was no significant relationship between vitamin D deficiency and the disease activity or severity in a sample of patients with RA.
维生素 D 具有免疫调节和抗炎作用,缺乏维生素 D 与许多自身免疫性疾病有关,包括类风湿性关节炎(RA)。类风湿性关节炎的严重程度与血清中维生素 D 水平之间的相关性是一个极具研究价值和治疗意义的课题。 研究人员从大学医院风湿病诊所的来访者中收集了 100 名曾被诊断为 RA 的患者,他们的年龄都在 18 岁以上。他们测量了血清维生素 D 值和 C 反应蛋白(CRP)值,并计算了疾病活动性评分 CRP28(DAS28CRP)和改良健康评估问卷(MHAQ)得分,以确定疾病的严重性和有效性及其与维生素 D 缺乏的关系。 根据患者的年龄,其平均年龄为(46.03±11.291)岁,我们注意到年龄在 26 岁至 65 岁之间的个体所占比例最大(94%),其中女性占 83%,男性占 17%,日晒的平均得分为(15.80±5.446)分。确诊患病时间在 5 至 10 年之间的患者比例最高,占 31%。共有 72% 的患者未接受皮质类固醇激素治疗,43% 的患者接受维生素 D 治疗。我们发现,使用生物制剂药物的患者人数占 18%,使用改变病情抗风湿药物的患者人数占 88%。63%的患者 DAS28 平均值为中度,MHAQ 平均值为(0.80±0.334)分。我们发现,血清维生素 D 水平与 DAS28/CRP 之间没有统计学意义的相关性(P=0.733),血清维生素 D 值与所用药物(无论是生物制剂还是改善病情抗风湿药物)之间也没有统计学意义的相关性(P=0.361)。此外,血清维生素 D 水平与 MHAQ 评分之间也无明显相关性(P=0.100)。 在RA患者样本中,维生素D缺乏与疾病活动性或严重程度之间没有明显关系。